Zai Lab Ltd. (ZLAB)
18.63
-0.47
(-2.46%)
USD |
NASDAQ |
May 22, 16:00
18.63
0.00 (0.00%)
After-Hours: 20:00
Zai Lab EPS Diluted (Quarterly) : -0.4621 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -0.6345 |
| Ascletis Pharma, Inc. | -- |
| CanSino Biologics, Inc. | -0.0236 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.17M |
| Revenue (Quarterly) | 99.91M |
| Total Expenses (Quarterly) | 151.08M |
| Enterprise Value | 1.611B |
| Gross Profit Margin (Quarterly) | 61.52% |
| Profit Margin (Quarterly) | -51.22% |
| Earnings Yield | -8.70% |
| Normalized Earnings Yield | -8.700 |